|
業務類別
|
Biotechnology |
|
業務概覽
|
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies. |
| 公司地址
| 3928 Point Eden Way, Hayward, CA, USA, 94545 |
| 電話號碼
| +1 510 694-6200 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.arcusbio.com |
| 員工數量
| 601 |
| Dr. Terry Rosen, PhD |
Chairman of the Board and Chief Executive Officer |
美元 775.00K |
21/04/2026 |
| Dr. Juan Carlos Jaen, PhD |
President |
美元 660.00K |
21/04/2026 |
| Mr. Robert C. Goeltz, II |
Chief Financial Officer and Principal Accounting Officer |
美元 540.00K |
21/04/2026 |
| Mr. Alexander Azoy |
Vice President, Finance and Principal Accounting Officer |
-- |
25/02/2026 |
| Ms. Carolyn C. Tang |
General Counsel |
-- |
21/04/2026 |
| Dr. Richard Markus, M.D.,PhD |
Chief Medical Officer |
美元 552.31K |
21/04/2026 |
|
|
| Mr. Patrick C. Machado, J.D. |
Independent Director |
21/04/2026 |
| Ms. Kathryn E. Falberg |
Independent Director |
21/04/2026 |
| Dr. Terry Rosen, PhD |
Chairman of the Board and Chief Executive Officer |
21/04/2026 |
| Dr. Andrew J. Perlman,M.D.,PhD |
Independent Director |
21/04/2026 |
| Dr. David L. Lacey, M.D. |
Independent Director |
21/04/2026 |
| Dr. Yasunori Kaneko, M.D. |
Lead Independent Director |
21/04/2026 |
| Dr. Dietmar Berger, M.D.,PhD |
Director |
21/04/2026 |
| Ms. Nicole Lambert |
Independent Director |
21/04/2026 |
| Ms. Johanna Mercier |
Director |
21/04/2026 |
| Dr. Antoni Ribas, M.D.,PhD |
Independent Director |
21/04/2026 |
| Dr. Linda Higgins, PhD |
Director |
21/04/2026 |
|
|
|
|
